Comptroller Sean Scanlon Releases Report On FlyteHealth GLP-1 Weight Management Program
Report highlights improved health outcomes and cost savings
(HARTFORD, CT) – Comptroller Sean Scanlon today released a The Segal Company highlighting the fiscal impact of the state health plan’s partnership with FlyteHealth for weight management among state and partnership plan employees, retirees, and their dependents.
“When I took office in 2023, the state employee health plan was seeing an unsustainable 50% year-over-year increase in spending on GLP-1 weight loss drugs. Rather than simply accept those rising costs or cut off members’ access to these life-changing drugs, we embarked on a third path with FlyteHealth, and it has worked.”
The analysis conducted revealed that the State of Connecticut FlyteHealth program, initiated by the Comptroller in 2023, has resulted in approximately $100 in medical savings per month per person enrolled, with more than 11,000 state employees participating and even larger savings in high-risk patients. Overall, the state saw an estimated $29.7 million in prescription cost savings in fiscal year 2024-2025 alone.
“People are getting healthier. And when that happens, our costs come down, they’re more productive at work, and most importantly, they lead more fulfilling lives,” said Comptroller Scanlon. “FlyteHealth has been an amazing partner to have, and I hear all the time from members about the lifechanging experiences they’ve had with this program. At a time when healthcare costs are skyrocketing, we’ve found the happy medium between curbing cost growth while also maintaining access to high-quality care.”
“The findings in the Segal report send a clear message: investing in high-quality, evidence-based cardio-kidney-metabolic care improves clinical outcomes and total cost of care,” said Sloan Saunders, President of FlyteHealth. “These results reflect the impact of FlyteHealth’s team-based care on engagement, adherence, and a data-driven approach to innovative chronic care delivery. Connecticut is setting a new standard for how public purchasers can improve lives while responsibly managing costs. We are proud to partner with Comptroller Scanlon and the State on a model that is delivering meaningful impact for members and taxpayers alike.”
According to Segal, the partnership has led to slower growth in prescription drug spending (including GLP-1s), reduced utilization of hospital visits, and improvements in cardiovascular health and overall mental health. The full Segal report can be accessed on the Office of the State Comptroller website.
For more information on the improved health outcomes associated with FlyteHealth (formerly known as Intellihealth), refer to Comptroller Scanlon’s announcement extending the partnership.
Download as PDF More News